pharmaphorum

JULY 18, 2025

Skip to main content Friday 18 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Pharmaceutical Companies

STAT

NOVEMBER 30, 2023

Food and Drug Administration approval for advanced ovarian cancer in 2022. Elahere is among a surging class of cancer medicines called antibody-drug conjugates, or ADCs, which are designed to deliver a targeted dose of chemotherapy directly to tumor cells while sparing healthy tissues. Continue to STAT+ to read the full story…

Compounding

European Pharmaceutical Review

OCTOBER 19, 2023

The development of novel radiotherapeutics ushered in a new era in targeted treatment 1 for cancer, with two separate radiotherapeutic approvals in Europe and the US, in 2018 and 2022. With alpha particles, you must be very careful how the drug is made to ensure that the compound remains stable between manufacturing and use.

Chemotherapy

pharmaphorum

DECEMBER 5, 2022

Pluvicto becomes the first PSMA-targeted intravenous radioligand therapy – combining a targeting compound or ligand with a therapeutic radionuclide or radioactive particle (in this case, lutetium-177) – to demonstrate clinical benefit in mCRPC patients before receiving taxane-based chemotherapy.

Chemotherapy

Pharmaceutical Technology

MARCH 23, 2023

The drug is currently licensed in combination with chemotherapy for patients with classical Hodgkin lymphoma, both as frontline therapy and for those at risk of progressing or having progressed following stem cell transplantation. Seagen generated almost $2 billion in revenue in 2022, an increase approaching 25% from 2021.

Chemotherapy

pharmaphorum

NOVEMBER 29, 2022

By enabling strong CD8 T-cell infiltration in cold tumor tissues, NT-I7, a compound developed by NeoImmuneTech, is capable of promoting a microenvironment that contributes to clinical efficacy, when combined with a CPI. Headquarters: Rockville, MD, USA (2400 Research Blvd., Suite 250, Rockville, MD 20850). Number of employees: 90+ (as of Oct.

Immunization

Pharmaceutical Technology

MAY 12, 2023

The agent is a human epidermal growth factor receptor 2 (HER2)-targeting ADC that utilises Eisai’s chemotherapy Halaven (eribulin) as its payload. GlobalData analyst consensus forecasts project sales to reach $11.5bn by 2029, a 29% compound annual growth rate (CAGR). targeting ADC.

Chemotherapy

European Pharmaceutical Review

JANUARY 3, 2023

Cisplatin and other platinum-based compounds are essential chemotherapeutic agents for many cancers, yet they can cause ototoxicity, permanent and irreversible hearing loss, which occurs in up to 50-60 percent of adult patients and 90 percent of paediatric patients who survive cancer. This control arm will provide natural history data.

Chemotherapy

Pharmaceutical Technology

AUGUST 12, 2022

billion by the end of 2022. By 2028, the market is expected to reach $25 billion, with a compound annual growth rate (CAGR) of 46.6%. The standard first-line treatment for DLBCL is a chemotherapy regimen, alongside the monoclonal antibody rituximab. Overall, the global CAR-T cell market for all indications was worth $1.7

Immunization

Blog: Ask a Student Pharmacist

JUNE 21, 2023

Jiashu Xie, PhD eomizowh Wed, 06/21/2023 - 10:11 Expand all + Biography Research Summary Current research in the Pharmacokinetics (PK) lab has focused on profiling the in vitro ADME (absorption, distribution, metabolism, and excretion) and in vivo PK properties of lead compounds from medicinal chemistry efforts. 2022; 129: 106198.

Compounding

The Checkup by Singlecare

JANUARY 10, 2024

Alpha 1 Globulins Alpha-1 globulins serve as transport proteins, which carry compounds to other tissues or organs in the body. Secondary hypogammaglobulinemia: In secondary hypogammaglobulinemia, low levels of immunoglobulin occur due to certain medical conditions or medicines, such as an immunosuppressant drug or chemotherapy.

Immunization

The Checkup by Singlecare

MARCH 23, 2023

Understanding the difference between CBD vs. marijuana Cannabinoids are compounds found in the cannabis plant, Cannabis sativa. They are prescribed to increase appetite in patients receiving chemotherapy. Marijuana , also called cannabis, contains more than 100 cannabinoids.

Controlled Substances

The Thyroid Pharmacist

NOVEMBER 4, 2022

While the human body (via the liver and kidneys) can produce up to 4 g/day of inositol, it has been found that the overly processed, high glucose (and low fiber) Western diets that many people follow, only provide about 1 g/day of the compound. (7). published online ahead of print, 2022 Apr 20]. Published March 11, 2022.

Dosage

The Thyroid Pharmacist

SEPTEMBER 20, 2024

Chemotherapy agents: Chemotherapy agents can lead to constipation in a variety of ways such as slowing the movements of the intestinal tract or creating inflammation that disrupts digestive function. Treasure Island (FL): StatPearls Publishing; January 21, 2022. [8] 2022 Jun 26;14(13):2641. Published 2022 Oct 26.

Health and Personal Care Stores

The Thyroid Pharmacist

SEPTEMBER 1, 2023

The fluorine anion (negatively charged ion), or any of the compounds containing the anion, are termed fluorides. Published 2022 Nov 2. In pure form, it is a highly-toxic, yellowish-green gas. Government of Canada, Ottawa. 30] Chaulagain R, Chhatkuli A, Shrestha AR, Chhetri BK, Pandey S. JNMA J Nepal Med Assoc. 2022;60(255):947-951.

Adverse Reactions

The Thyroid Pharmacist

JULY 8, 2022

It’s important to note that selenium may also interact with other supplements and medications, such as cholesterol-lowering statin drugs, antacids, chemotherapy drugs, corticosteroids, niacin, and even birth control pills. Institute of Medicine (US) Panel on Dietary Antioxidants and Related Compounds. Published 2022 Mar 14.

Dosage

The FDA Law Blog

FEBRUARY 11, 2024

Few would oppose FDA-approved marijuana-derived medications if marijuana compounds are found to have medical value; the National Institute of Health should continue to fund research on any potential medical value of marijuana and on the harms of highly potent products. July 6, 2022). Letter to President Joseph Biden, et al.

Controlled Substances

Hospital Pharmacy Europe

APRIL 1, 2025

Assessing the carbon footprint A retrospective evaluation was conducted in a French university hospitals cytotoxic production unit from January to December 2022, covering approximately 51,000 preparations and 24,700 prescriptions. In 2022, the unit prepared approximately 46,000 licensed antineoplastic therapies. tons of CO2e, 7.1%).

Intravenous Solutions

The Thyroid Pharmacist

NOVEMBER 29, 2024

Some report more weight loss with T4/T3 combinations (Armour*, Nature-Throid, compounded medications) versus T4 medications (Synthroid, Levoxyl, Tirosint) alone. Published 2022 Feb 22. Published 2022 Nov 16. doi:10.1136/openhrt-2022-001989; Bizzarri M, Monti N, Piombarolo A, Angeloni A, Verna R. Published 2018 Oct 18.

Health and Personal Care Stores